Global External Neuromodulation Market By Type (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation), By Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 138742
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global External Neuromodulation Market is estimated to be valued US$ XX.X million in 2019. The report on External Neuromodulation Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global external neuromodulation market is segmented on the basis of Type, Application, and geography.
In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.
External Neuromodulation Market Scope:
By type, the market is segmented into Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation. By Application, the market is divided into Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, and Others.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Medtronic Inc., Boston Scientific Corporation, St. Jude Medical Inc., Synapse Biomedical Inc., Nevro Corporation, Neurosigma Inc., Neuropace Inc., Neuronetics Inc., Cyberonics Inc., and BioControl Medical (Israel).Key Market Segments
Type
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Key Market Players included in the report:
Medtronic Inc.
Boston Scientific Corporation
St. Jude Medical Inc.
Synapse Biomedical Inc.
Nevro Corporation
Neurosigma Inc.
Neuropace Inc.
Neuronetics Inc.
Cyberonics Inc.
BioControl Medical (Israel)
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and External Neuromodulation Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of External Neuromodulation Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers External Neuromodulation Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global External Neuromodulation Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the External Neuromodulation Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the External Neuromodulation Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of External Neuromodulation sub-markets, depending on key regions (various vital states).
To analyze External Neuromodulation Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the External Neuromodulation Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide External Neuromodulation Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. External Neuromodulation Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global External Neuromodulation Market Overview
3.1. External Neuromodulation Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global External Neuromodulation Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global External Neuromodulation Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Transcutaneous Electrical Nerve Stimulation4.4. Transcranial Magnetic Stimulation
4.5. Respiratory Electrical Stimulation
5. Global External Neuromodulation Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global External Neuromodulation Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Spinal Cord Stimulation5.4. Deep Brain Stimulation
5.5. Sacral Nerve Stimulation
5.6. Others
6. Global External Neuromodulation Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America External Neuromodulation Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe External Neuromodulation Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific External Neuromodulation Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America External Neuromodulation Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa External Neuromodulation Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global External Neuromodulation Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Medtronic#Inc.7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Boston Scientific Corporation
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. St. Jude Medical#Inc.
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Synapse Biomedical#Inc.
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Nevro Corporation
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Neurosigma#Inc.
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Neuropace#Inc.
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Neuronetics#Inc.
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Cyberonics#Inc.
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. BioControl Medical (Israel)
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
